Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 3541–3560 of 17,529 recalls

April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: PGE-3

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: RE-2

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution

The Issue: Failed Reconstitution time

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: SB-6

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: Sermorelin Acetate

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: AT-6

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: ST-2

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Olympia Compounding Pharmacy dba Olympia Pharmacy

Recalled Item: BIMIX-3

The Issue: CGMP Deviations: prior to October 1, 2021, environmental

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 4, 2022· Beak & Skiff Cider Mill, Inc.

Recalled Item: BEAK & SKIFF SANITIZER Alcohol Antiseptic 80%

The Issue: CGMP Deviations: FDA analysis found product to contain

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 1, 2022· Wellness BioSciences

Recalled Item: CBD Metered Dose Inhaler (CBD) 5 mg Dose

The Issue: Marketed Without an Approved NDA/ANDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 1, 2022· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Esomeprazole Magnesium Delayed-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 1, 2022· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Esomeprazole Magnesium Delayed-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 1, 2022· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Methylprednisolone Tablets

The Issue: Subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 1, 2022· Mylan Pharmaceuticals Inc

Recalled Item: Travoprost Ophthalmic Solution

The Issue: Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-spec

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 1, 2022· The Ritedose Corporation

Recalled Item: 23.4% Sodium Chloride Injection

The Issue: Labeling: Incorrect Barcode: Product barcode incorrectly identifies the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 1, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Cequa (cyclosporine ophthalmic solution) 0.09%

The Issue: Subpotent Drug and Presence of Particulate Matter: low

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 31, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: Losartan Potassium Tablets USP

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 31, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: Losartan Potassium Tablets USP

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 31, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets USP

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 31, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets USP

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund